This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred COVID-19 is on the upswing in California and ...
The grades are in! The Texas Education Agency released its new ratings for the 2025-2026 school year. Here's how you can find ...
The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S. Abbott will pay Freenome $100 million as part of a 2025 deal ...
A Chicago lab owner pleaded guilty Wednesday to conspiring with fugitive ex-Loretto Hospital executive Anosh Ahmed in a COVID ...
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening – – Medicare coverage and American Cancer Society guidance support broader ...
FDA has approved Freenome’s Simple Screen CRC, a blood-based test for colorectal cancer. Abbott Laboratories will exclusively commercialize the test in the U.S. in the fall, according to a release.
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Texas Governor Greg Abbott and Democrat Gina Hinojosa are locked in a ...
As if you needed another health concern to worry about — beyond the “explosive diarrhea” stomach parasite causing a surge of sicknesses around the United States — the COVID-19 virus has made a ...
It looks like a blissful summer to be a Centrist Dad. Andy Burnham, sunning himself on a beach somewhere, is also cresting a ...
A clash over border controls and diversity is heating up as Anthony Albanese tries to balance support for migrant communities ...
When his brother persuaded him to enter a 10km race during the Covid-19, the civil engineer and former footballer wasn't even sure he could finish the distance ...
James Coles on his Hundred payday, Sussex success and England ambitions: ‘I’ll do whatever it takes’ - EXCLUSIVE INTERVIEW: One of English cricket’s brightest talents sits down with Harry Latham-Coyle ...